GCA
WST icon

Gideon Capital Advisors’s West Pharmaceutical WST Stock Holding History

Gideon Capital Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-4,109
Closed -$403K – 532
2018
Q4 		$403K Buy
+4,109
New +$446K 0.16% 194

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Gideon Capital Advisors's WST Position: Q1 2019 in Review

Gideon Capital Advisors sold out of West Pharmaceutical (WST) in Q1 2019, closing a stake of 4,109 shares — an estimated $403K sold.

Gideon Capital Advisors first reported a position in WST in Q4 2018 and held it in 1 quarter. The position peaked at $403K in Q4 2018. 379 funds tracked by Wall St. Rank hold WST as of Q1 2019.

  • Gideon Capital Advisors reported no remaining West Pharmaceutical position as of Q1 2019 after selling out during the quarter.
  • Gideon Capital Advisors sold 4,109 West Pharmaceutical shares in Q1 2019, an estimated $403K.
  • Gideon Capital Advisors first reported a position in West Pharmaceutical in Q4 2018 and held it in 1 quarter.
  • Gideon Capital Advisors's West Pharmaceutical position peaked at $403K in Q4 2018.
  • 379 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2019.

Based on Gideon Capital Advisors's 13F filing for Q1 2019, filed 14 May 2019.